XML 18 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)      
Revenues $ 211,949,000 $ 165,557,000 $ 201,998,000
Cost of goods sold 204,010,000 154,532,000 189,300,000
Gross profit 7,939,000 11,025,000 12,698,000
Research and development expenses 88,000 213,000 205,000
Selling, general and administrative expenses 23,676,000 16,882,000 17,424,000
Operating loss (15,825,000) (6,070,000) (4,931,000)
Interest expense      
Interest rate expense 20,136,000 22,943,000 21,089,000
Debt related fees and amortization expense 3,921,000 3,401,000 4,666,000
Accretion and other expenses of Series A preferred units 7,718,000 4,673,000 2,257,000
Loss contingency on litigation 0 0 6,200,000
Gain on debt extinguishment (1,134,000) 0 0
Other expense (income) 809,000 548,000 (797,000)
Loss before income taxes (47,275,000) (37,635,000) (38,346,000)
Income tax expense (benefit) (128,000) (976,000) 1,131,000
Net loss (47,147,000) (36,659,000) (39,477,000)
Less: Net loss attributable to non-controlling interest 0 0 (3,761,000)
Net loss attributable to Aemetis, Inc. (47,147,000) (36,659,000) (35,716,000)
Other comprehensive (loss)      
Foreign currency translation loss (236,000) (289,000) (249,000)
Comprehensive loss $ (47,383,000) $ (36,948,000) $ (39,726,000)
Net loss per common share      
Basic $ (1.54) $ (1.74) $ (1.75)
Diluted $ (1.54) $ (1.74) $ (1.75)
Weighted average shares outstanding      
Basic 30,682 21,012 20,467
Diluted 30,682 21,012 20,467